These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 22836064)
21. From the editor: selling the benefit of drug therapy. Brown WV J Clin Lipidol; 2013; 7(1):1-2. PubMed ID: 23351576 [No Abstract] [Full Text] [Related]
22. HDL and LDL as therapeutic targets for cardiovascular disease prevention: the possible role of niacin. Olsson AG Nutr Metab Cardiovasc Dis; 2010 Oct; 20(8):553-7. PubMed ID: 20739153 [TBL] [Abstract][Full Text] [Related]
25. Raising HDL-C: back to the future? Wierzbicki AS Int J Clin Pract; 2007 Jul; 61(7):1069-71. PubMed ID: 17577290 [No Abstract] [Full Text] [Related]
26. Role of ezetimibe in the prevention of cardiovascular disease: absence of evidence. Mascitelli L; Pezzetta F; Goldstein MR Arch Med Res; 2010 Nov; 41(8):649-50. PubMed ID: 21199735 [TBL] [Abstract][Full Text] [Related]
27. Hormones and... many symptoms of menopause means many therapies. Levine S; Brink S; Hobson K; Carpenter B; Malrine A US News World Rep; 2002 Nov; 133(19):63, 67-70. PubMed ID: 12501477 [No Abstract] [Full Text] [Related]
28. Study suggests statins for diabetics with healthy LDL cholesterol levels. Rollins G Rep Med Guidel Outcomes Res; 2004 Sep; 15(18):1-2, 6-7. PubMed ID: 15452942 [No Abstract] [Full Text] [Related]
29. The case for medical treatment in chronic stable coronary artery disease. Nash DT Arch Intern Med; 2005 Dec 12-26; 165(22):2587-9, discussion 2593-4. PubMed ID: 16344414 [No Abstract] [Full Text] [Related]
30. Distinct effects of pitavastatin and atorvastatin on lipoprotein subclasses in patients with Type 2 diabetes mellitus. Shimabukuro M; Higa M; Tanaka H; Shimabukuro T; Yamakawa K; Masuzaki H Diabet Med; 2011 Jul; 28(7):856-64. PubMed ID: 21244474 [TBL] [Abstract][Full Text] [Related]
31. [Lipid therapy in risk patients. Do we concentrate too much on LDL cholesterol?]. März W MMW Fortschr Med; 2005 Apr; 147(14):14. PubMed ID: 15887675 [No Abstract] [Full Text] [Related]
32. Lipid management with statins. The lower the better? Laufs U; Liao JK; Böhm M Z Kardiol; 2004 Jan; 93(1):4-9. PubMed ID: 14740235 [TBL] [Abstract][Full Text] [Related]
33. How should we define hypercholesterolemia? Tonkin AM Curr Atheroscler Rep; 2000 Jul; 2(4):273-4. PubMed ID: 11122753 [No Abstract] [Full Text] [Related]
34. [Strengthened support for statin therapy as secondary prevention. Doubtful evidence for more intensive lowering of cholesterol levels]. Håkansson J Lakartidningen; 2011 Jun 1-14; 108(22-23):1234-5. PubMed ID: 21786497 [No Abstract] [Full Text] [Related]
35. [Favorable effects of decreasing lipids in patients with diabetes mellitus]. Gouni-Berthold I; Krone W Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S252-4. PubMed ID: 17139581 [TBL] [Abstract][Full Text] [Related]
36. Statins. Cholesterol treatment and beyond. Mayo Clin Health Lett; 2004 Nov; 22(11):1-3. PubMed ID: 15619748 [No Abstract] [Full Text] [Related]
37. Advances in the management of hyperlipidemia-induced atherosclerosis. Tannock LR Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):369-83. PubMed ID: 18327996 [TBL] [Abstract][Full Text] [Related]
38. [Intensive LDL lowering to under 80 mg/dl: hypercholesteremia patients with stable coronary disease and diabetes profit especially significantly]. MMW Fortschr Med; 2005 Aug; 147(33-34):50-1. PubMed ID: 16138640 [No Abstract] [Full Text] [Related]
39. What about Niacin? Medical Letter Med Lett Drugs Ther; 2011 Nov; 53(1378):93-4. PubMed ID: 22113122 [No Abstract] [Full Text] [Related]
40. High HDL may not protect the heart. Concentrate on lowering LDL for now, experts advise. Harv Heart Lett; 2012 Sep; 23(1):6. PubMed ID: 23097807 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]